Drugs / Autologous cell therapy
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT03984461 Comparator | Sep 2020 → Dec 2027 expected | osteoarthritis | Dr. Grant M. Pagdin | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous cell therapy | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03984461 ↗ |
| Modality | Cell therapy | “Autologous cell therapy” NCT03984461 ↗ |